Antibodies Against Three Novel Peptides in Early Axial Spondyloarthritis Patients From Two Independent Cohorts.

Dana QuadenPatrick VandormaelPieter RuytinxPiet GeusensKristoff CortenJohan VanhoofJori LiesenborgsFrank van ReethAnouk AgtenFrank VandenabeeleKurt de VlamVeerle Somers

Published in: Arthritis & rheumatology (Hoboken, N.J.) (2020)

Antibodies to 3 UH-axSpA peptides could provide a novel tool in the diagnosis of a subset of axial SpA patients.

Keyphrases

end stage renal disease
ejection fraction
prognostic factors
peritoneal dialysis
rheumatoid arthritis
patient reported outcomes
systemic lupus erythematosus
patient reported